A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morn...
Main Authors: | Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | Clinical Pharmacology : Advances and Applications |
Online Access: | https://www.dovepress.com/corrigendum-a-randomized-direct-comparison-of-the-pharmacokinet-peer-reviewed-article-CPAA |
Similar Items
-
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
by: Frost C, et al.
Published: (2014-11-01) -
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
by: Frost C, et al.
Published: (2018-10-01) -
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
by: Upreti VV, et al.
Published: (2013-04-01) -
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
by: Cui Y, et al.
Published: (2014-03-01) -
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
by: Cui Y, et al.
Published: (2013-12-01)